HRP20040691A2 - 2'-halo-3',5'-dialkoxyphen-1'-yl-imino-2-imidazolidine and the use thereof as a drug - Google Patents

2'-halo-3',5'-dialkoxyphen-1'-yl-imino-2-imidazolidine and the use thereof as a drug

Info

Publication number
HRP20040691A2
HRP20040691A2 HRP20040691A HRP20040691A2 HR P20040691 A2 HRP20040691 A2 HR P20040691A2 HR P20040691 A HRP20040691 A HR P20040691A HR P20040691 A2 HRP20040691 A2 HR P20040691A2
Authority
HR
Croatia
Prior art keywords
dialkoxyphen
imidazolidine
imino
halo
drug
Prior art date
Application number
Other languages
English (en)
Inventor
Franz Esser
Pascale Pouzet
Naoki Ishhiguro
Hisato Kitagawa
Ikunobu Muramatsu
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of HRP20040691A2 publication Critical patent/HRP20040691A2/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/44—Nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/44—Nitrogen atoms not forming part of a nitro radical
    • C07D233/50—Nitrogen atoms not forming part of a nitro radical with carbocyclic radicals directly attached to said nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
HRP20040691 2002-01-31 2004-07-29 2'-halo-3',5'-dialkoxyphen-1'-yl-imino-2-imidazolidine and the use thereof as a drug HRP20040691A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02002352A EP1333028A1 (en) 2002-01-31 2002-01-31 2'-Halo-3',5'-dialkoxyphen-1'-yl-imino-2-imidazolidine derivatives and the use thereof for the treatment of urinary incontinence
PCT/EP2002/014299 WO2003064398A1 (en) 2002-01-31 2002-12-16 2'-halo-3',5'-dialkoxyphen-1'-yl-imino-2-imidazolidine derivatives and the use thereof for the treatment of urinary incontinence

Publications (1)

Publication Number Publication Date
HRP20040691A2 true HRP20040691A2 (en) 2004-12-31

Family

ID=8185397

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20040691 HRP20040691A2 (en) 2002-01-31 2004-07-29 2'-halo-3',5'-dialkoxyphen-1'-yl-imino-2-imidazolidine and the use thereof as a drug

Country Status (20)

Country Link
EP (2) EP1333028A1 (xx)
JP (1) JP2005516066A (xx)
KR (1) KR20040074134A (xx)
CN (1) CN1617857A (xx)
AR (1) AR038380A1 (xx)
BR (1) BR0215560A (xx)
CA (1) CA2474588A1 (xx)
EA (1) EA200400877A1 (xx)
EC (1) ECSP045210A (xx)
HR (1) HRP20040691A2 (xx)
HU (1) HUP0402654A2 (xx)
IL (1) IL162776A0 (xx)
MX (1) MXPA04007250A (xx)
NO (1) NO20043614L (xx)
PE (1) PE20030819A1 (xx)
PL (1) PL369826A1 (xx)
TW (1) TW200418462A (xx)
UY (1) UY27628A1 (xx)
WO (1) WO2003064398A1 (xx)
ZA (1) ZA200405173B (xx)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4168086B1 (ja) * 2008-04-16 2008-10-22 国立大学法人福井大学 イミダゾリン誘導体
US20090286829A1 (en) * 2008-05-13 2009-11-19 Allergan, Inc. Quinolynylmethylimidizoles as therapeutic agents
US8258167B2 (en) 2008-05-13 2012-09-04 Allergan, Inc Naphthylmethylimidizoles as therapeutic agents
US8063231B2 (en) * 2008-06-09 2011-11-22 Allergan, Inc. Methods of treating alpha adrenergic mediated conditions
EP2303264B1 (en) * 2008-06-09 2018-04-04 Allergan, Inc. Methods of treating alpha adrenergic mediated conditions using imidazoline derivatives
US9034910B2 (en) 2008-06-09 2015-05-19 Allergan, Inc. Methods of treating alpha adrenergic mediated conditions

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2220906A1 (de) * 1972-04-28 1973-11-15 Boehringer Sohn Ingelheim Neue substituierte 2-phenylaminoimidazoline-(2), deren saeureadditionssalze sowie verfahren zu deren herstellung
DE2259160A1 (de) * 1972-12-02 1974-06-06 Boehringer Sohn Ingelheim Neue substituierte 2-phenylaminoimidazoline, deren saeureadditionssalze und verfahren zur herstellung derselben sowie ihre verwendung als arzneimittel
AT333749B (de) * 1974-07-03 1976-12-10 Chemie Linz Ag Verfahren zur herstellung von neuen 2-arylamino-2-imidazolinderivaten
MTP837B (en) * 1977-11-07 1979-10-22 Hoffman La Roche And Co Aktien Derivatives 2 finino-imidazolidire
DE3514351A1 (de) * 1985-04-20 1986-11-06 Boehringer Ingelheim KG, 6507 Ingelheim Neue substituierte 2-(n-alkinyl-n-phenyl)amino)-imidazolinderivate, deren saeureadditionssalze, diese enthaltende arzneimittel und verfahren zu deren herstellung
DE19514579A1 (de) * 1995-04-20 1996-10-24 Boehringer Ingelheim Kg Verwendung von alpha¶1¶¶L¶-Agonisten zur Behandlung der Harninkontinenz
SG72827A1 (en) * 1997-06-23 2000-05-23 Hoffmann La Roche Phenyl-and aminophenyl-alkylsulfonamide and urea derivatives
DE19740176C2 (de) * 1997-09-12 2000-04-06 Lemfoerder Metallwaren Ag Handschaltvorrichtung für ein Kraftfahrzeug

Also Published As

Publication number Publication date
IL162776A0 (en) 2005-11-20
EP1472231A1 (en) 2004-11-03
PL369826A1 (en) 2005-05-02
KR20040074134A (ko) 2004-08-21
JP2005516066A (ja) 2005-06-02
NO20043614L (no) 2004-08-30
EP1333028A1 (en) 2003-08-06
CA2474588A1 (en) 2003-08-07
ZA200405173B (en) 2005-06-21
BR0215560A (pt) 2004-12-21
EA200400877A1 (ru) 2005-02-24
TW200418462A (en) 2004-10-01
UY27628A1 (es) 2003-08-29
ECSP045210A (es) 2004-09-28
CN1617857A (zh) 2005-05-18
AR038380A1 (es) 2005-01-12
HUP0402654A2 (hu) 2005-03-29
MXPA04007250A (es) 2004-10-29
WO2003064398A1 (en) 2003-08-07
PE20030819A1 (es) 2003-10-20

Similar Documents

Publication Publication Date Title
IL219671A0 (en) 1,2- benzoxazoles and use thereof in the preparation of a medicament
AU2001256184A1 (en) 6-aminoalkyl-dihydropyrimidines and the use thereof as medicaments against viraldiseases
EP1575534A4 (en) D4.5 GLYCURONIDASE AND ITS USES
HK1080482A1 (en) Novel thiophenylglycoside derivatives, methods forproduction thereof, medicaments comprising said c ompounds and use thereof
HK1123806A1 (en) Xanthine derivative, production and use thereof as a medicament
HRP20020375A2 (en) Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and the use thereof
SI1555267T1 (sl) 2,3-DIHIDRO-6-NITROIMIDAZO(2,1-b)OKSAZOLI
ZA200502496B (en) Ester compound and medicinal use thereof.
HK1078851A1 (en) 2-Indolinone-monoethanesulphonate and the use thereof in preparing a pharmaceutical composition
EP1617807A4 (en) SUBSTITUTED 1,4-DIAZEPINE AND ITS USES
ZA200305498B (en) Xanthine derivative, production and use thereof as a medicament.
IL143349A0 (en) Azepinoindole derivatives, the production and use thereof
HUP0203290A3 (en) Indeno-, naphto-, and benzocyclohepta-dihydrothiazole derivatives, the production thereof and their use as anorectic medicaments
HK1081954A1 (en) Novel 1,4-diazabicycloalkane derivatives, their preparation and use
SI1268522T1 (sl) Novi antagonisti lhrh, njihova priprava in uporaba kot zdravila
TWI348382B (en) N-acetylglucosamine derivatives, and the use thereof
HUP0300222A3 (en) Novel lhrh-antagonists, production and use thereof as medicament
HRP20040691A2 (en) 2'-halo-3',5'-dialkoxyphen-1'-yl-imino-2-imidazolidine and the use thereof as a drug
AU2003232785A1 (en) Novel anthracene derivatives and the use thereof as a medicament
ZA200303991B (en) "Polymerization".
HUP0402671A3 (en) Substituted 3-phenyl-5-alkoxy-1,3,4-oxadiazol-2-ones, the production thereof and their use in medicaments
GB2386580B (en) The bricky's mate
AU2003232698A1 (en) Use of a n,n'-dibenzyl-thiourea as medicine
ZA200502794B (en) 2"Oxo-voruscharin and derivatives thereof.
GB0211597D0 (en) 't.d.t's

Legal Events

Date Code Title Description
A1OB Publication of a patent application
OBST Application withdrawn